Endra Life SciencesNDRA
13F holders, Q1 2026 (March 31)8holders +1
2new positions
2sold out
$4.65avg. 13F price*
At the end of Q1 2026, 8 institutions reported holding Endra Life Sciences Inc. (NDRA) in their 13F filings, up 1 from Q4 2025. 2 opened new positions and 2 sold out. The largest holders were Altium Capital Management LLC ($241K), Geode Capital Management, LLC ($98K) and Vanguard Fiduciary Trust Co. ($47K).
- Company
- Endra Life Sciences Inc.
- CUSIP
- 29273B500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $98K |
| Exits | 2 | $50 |
All 13F filers, Q4 2025 → Q1 2026: 21,222 shares bought and 3,411 shares sold, net +17,811 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Altium Capital Management LLC | 0.57% | No change | 51,900 | $241K |
| Geode Capital Management, LLC | 0.00% | New | 21,078 | $98K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 10,121 | $47K |
| Morgan Stanley | 0.00% | Reduce -49.0% | 3,546 | $16K |
| Vanguard Capital Management LLC | 0.00% | — | 2,816 | $13K |
| UBS Group AG | 0.00% | Add +1166.7% | 152 | $707 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 19 | $88 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 4 | $19 |
"% of holder's portfolio" is NDRA's weight in each manager's 13F, not the share of Endra Life Sciences Inc. the manager owns.